Cargando…
The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923898/ https://www.ncbi.nlm.nih.gov/pubmed/35307245 http://dx.doi.org/10.1016/j.ejim.2022.03.015 |
| _version_ | 1784669748608368640 |
|---|---|
| author | Calabretta, F. Preti, P.S. Russo, M. Klersy, C. Di Sabatino, A. |
| author_facet | Calabretta, F. Preti, P.S. Russo, M. Klersy, C. Di Sabatino, A. |
| author_sort | Calabretta, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8923898 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89238982022-03-16 The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients Calabretta, F. Preti, P.S. Russo, M. Klersy, C. Di Sabatino, A. Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2022-07 2022-03-16 /pmc/articles/PMC8923898/ /pubmed/35307245 http://dx.doi.org/10.1016/j.ejim.2022.03.015 Text en © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Calabretta, F. Preti, P.S. Russo, M. Klersy, C. Di Sabatino, A. The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
| title | The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
| title_full | The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
| title_fullStr | The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
| title_full_unstemmed | The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
| title_short | The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
| title_sort | role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized covid-19 patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923898/ https://www.ncbi.nlm.nih.gov/pubmed/35307245 http://dx.doi.org/10.1016/j.ejim.2022.03.015 |
| work_keys_str_mv | AT calabrettaf theroleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT pretips theroleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT russom theroleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT klersyc theroleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT disabatinoa theroleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT calabrettaf roleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT pretips roleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT russom roleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT klersyc roleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients AT disabatinoa roleofheparininreducinginhospitalcomplicationsandthreemonthmortalityratesinhospitalizedcovid19patients |